# Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Device and the Panbio™ COVID-19/Flu A&B Rapid Panel Self-Test Device

> **NCT05715515** · NA · COMPLETED · sponsor: **Abbott Rapid Dx** · enrollment: 903 (actual)

## Conditions studied

- COVID-19
- Influenza A
- Influenza Type B

## Interventions

- **DIAGNOSTIC_TEST:** Panbio™

## Key facts

- **NCT ID:** NCT05715515
- **Lead sponsor:** Abbott Rapid Dx
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-06
- **Primary completion:** 2023-05-29
- **Final completion:** 2023-05-29
- **Target enrollment:** 903 (ACTUAL)
- **Last updated:** 2023-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05715515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05715515, "Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Device and the Panbio™ COVID-19/Flu A&B Rapid Panel Self-Test Device". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05715515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*